Lupin to market Novartis' inhaler under Loftair brand name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India
Apr 11, 2016, 17:24 PM IST
HC restrains Cipla from selling drug containing Indacaterol
The court said the restraint on Cipla will remain till its application for compulsory license is decided by the relevant authority.
Jan 09, 2015, 23:51 PM IST
HC order 'disappointing', says Cipla
Drug maker Cipla Friday expressed disappointment over the Delhi High Court order that restrained the company from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to drugs they need.
Jan 09, 2015, 23:10 PM IST
Novartis sues India's Cipla over respiratory drug Onbrez
Swiss drugmaker Novartis AG said on Wednesday it had sued India`s Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug`s price.
Dec 17, 2014, 19:21 PM IST
